PSC
NUVA

Piper Sandler & Co’s NuVasive, Inc. NUVA Stock Holding History

Piper Sandler & Co’s Portfolio NUVA Stock Details NUVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-8,500
Closed -$410K – 77
2015
Q3 		$410K Buy
+8,500
New +$439K 0.44% 26

Other funds holding NUVA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AIM
Assured Investment Management New York $79.5M AUM 115.55% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Piper Sandler & Co's NUVA Position: Q4 2015 in Review

Piper Sandler & Co sold out of NuVasive, Inc. (NUVA) in Q4 2015, closing a stake of 8,500 shares — an estimated $410K sold.

Piper Sandler & Co first reported a position in NUVA in Q3 2015 and held it in 1 quarter. The position peaked at $410K in Q3 2015. 233 funds tracked by Wall St. Rank hold NUVA as of Q4 2015.

  • Piper Sandler & Co reported no remaining NuVasive, Inc. position as of Q4 2015 after selling out during the quarter.
  • Piper Sandler & Co sold 8,500 NuVasive, Inc. shares in Q4 2015, an estimated $410K.
  • Piper Sandler & Co first reported a position in NuVasive, Inc. in Q3 2015 and held it in 1 quarter.
  • Piper Sandler & Co's NuVasive, Inc. position peaked at $410K in Q3 2015.
  • 233 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q4 2015.

Based on Piper Sandler & Co's 13F filing for Q4 2015, filed 16 Feb 2016.